Search - tctmd.com

Displaying 381 - 400 of 563

Sort: Relevancy | Date

News Daily News

European Registries Show Solid Gains in TAVR Outcomes

Caitlin E. Cox

January 13, 2013

News Industry News

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

January 07, 2013

News Daily News

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

Caitlin E. Cox

January 02, 2013

News Daily News

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

Caitlin E. Cox

December 26, 2012

News Industry News

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

News Daily News

SCAI Updates Recommendations for Ad Hoc PCI

Yael L. Maxwell

December 02, 2012

News Daily News

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

November 28, 2012

News Daily News

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

November 28, 2012

News Daily News

ZEN Publicó: Colocación de stent en la arteria pélvica ayuda a tratar la disfunción eréctil en algunos pacientes

November 27, 2012

News Conference News TCT 2012

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

November 18, 2012

News Daily News

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

Caitlin E. Cox

November 15, 2012

News Conference News AHA 2012

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

Jason Kahn

November 06, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Conference News AHA 2012

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

November 04, 2012

News Industry News

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

October 31, 2012

News Conference News TCT 2012

PARTNER: Benefits of TAVR Sustained Out to 3 Years

October 25, 2012

News Conference News TCT 2012

Experts Discuss Future of Renal Denervation

October 25, 2012

News Industry News

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

October 25, 2012

Advertisement

European Registries Show Solid Gains in TAVR Outcomes

CardioKinetix Initiates Landmark Study of First-of-Its-Kind Treatment for

Year in Review: Physicians Highlight the Most Important Interventional News of 2012

‘Top Ten’ Advances of 2012 Highlighted by AHA-ASA, ACC

St. Jude Medical Enrolls First Patient in ILUMIEN I Study to Develop Guidance for Stent Optimization

Genetic Alleles Affect Response to Prasugrel in ACS Patients

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

SCAI Updates Recommendations for Ad Hoc PCI

Meta-analysis Questions Benefit of Longer Dual Antiplatelet Therapy Post-PCI

Meta-análisis cuestiona beneficio de la terapia antiplaquetaria doble extendida después la PCI

ZEN Publicó: Colocación de stent en la arteria pélvica ayuda a tratar la disfunción eréctil en algunos pacientes

ETAP Trial: Nitinol Stent Bests Angioplasty for Popliteal Artery Disease

BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES

OLIVE: Endovascular Treatment Shows Positive Results for Critical Limb Ischemia

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

FREEDOM: CABG Superior to PCI in Diabetic Patients with Multivessel Disease

Boston Scientific Receives CE Mark Approval for the SYNERGY™ Everolimus-Eluting Platinum Chromium Coronary Stent System, Featuring A Novel Bioabsorbable Polymer Coating

PARTNER: Benefits of TAVR Sustained Out to 3 Years

Experts Discuss Future of Renal Denervation

Elixir Medical Announces Enrollment Completion of the DESolve Nx Pivotal Trial for Fully Bioresorbable Coronary Scaffold System

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content